Details of the Drug

General Information of Drug (ID: DM1AQLW)

Drug Name

Otilimab

Synonyms

Otilimab [USAN]; UNII-Y8127R3VCH; Y8127R3VCH; MOR103; GSK3196165; 1638332-55-4; human monoclonal antibody

Indication

Disease Entry	ICD 11	Status	REF
Rheumatoid arthritis	FA20	Phase 3	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[2]
------------------------------------------------------------------------------------

Therapeutic Class

Antiviral Agents

Drug Type

Monoclonal antibody

Cross-matching ID

Repurposed Drugs (RPD)

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HUMAN colony-stimulating factor (GM-CSF)	TTPZGYX	CSF2_HUMAN	Inhibitor	[3]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04333147) Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT04376684) Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease. U.S. National Institutes of Health.
3	The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020 Apr 17:102468.